Market Research Future adds new report of “Vulvar Cancer Market Research Report” it contains Company information, geographical data and Table of Content
Global Vulvar Cancer Market Research Report, by Types (adenocarcinoma, squamous cell carcinomas, melanoma, sarcoma), by Treatment (radiation therapy, chemotherapy, surgery, drug treatment) and by End User (hospitals and clinics, cancer research institutes) – Forecast Till 2023
Market Synopsis of Global Vulvar Cancer Market:
Vulvar cancer is a rare disease that comprises of a malignant and invasive growth in the vulva. Being a rare disease it accounts for only 0.6- 0.7 % of total cancer diagnosis. Labia majora is the common site of this cancer as compared to labia minora. The major driving factor for this market is increasing prevalence of different types of like vulvar and vaginal cancer and changing lifestyle which is responsible for causing this cancer. On other hand high price associated with this disease and number of adverse effect of treatment may hamper the growth of this market.
Global vulvar cancer market is expected to grow at a CAGR of 5.8% during forecasted period of 2017-2023.
Global vulvar cancer market is segmented
- on the basis of of vulvar cancer which includes adenocarcinoma, squamous cell carcinomas, melanoma, sarcomaand other.
- On the basis of treatment the market is segmented as radiation therapy, chemotherapy, surgery and drugs treatment. Surgery is further sub segmented into excision, radical vulvectomy, partial vulvectomy and other.
- On the basis of end user the market is segmented into hospitals and clinics, cancer research institutes and other.
On regional basis the global vulvar cancer market is segmented into North America, Europe, Asia Pacific and Middle East and Africa. North America contribute the largest share in the market of vulvar cancer. Due to increasing prevalence of cancer in this region this market is expecting a swift growth. Europe is the second largest market followed by Asia Pacific. The outstanding development of healthcare sector in Asia Pacific region, it is responsible for the highest growth rate of this market in this region.
Key Players for Global Vulvar Cancer Market
This market has various players, some of the key players in this market are
- Abbott Diagnostics (US)
- Ono pharmaceutical co ltd (Japan)
- PDS Biotechnology Corporation (US)
- Becton Deckinson and Company (US)
- Siemens Healthcare (Germany)
- Qiagen (Germany)
- ISA Pharmaceuticals B.V. (Netherland)
- ORYX GmbH & Co. KG (Germany)
- Johnson & Johnson (US)
- Novartis AG (Switzerland)
- Hoffmann-La Roche Ltd (Switzerland)
- Celgene Corporation (US), Merck&Co.(US)
Table of Content
2 RESEARCH METHODOLOGY
3 MARKET DYNAMICS
4 MARKET FACTOR ANALYSIS
5. GLOBAL PAIN MANAGEMENT DEVICES MARKET, BY DEVICE TYPE
6. ABLATION DEVICES.
7. GLOBAL PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION
8. GLOBAL PAIN MANAGEMENT DEVICES MARKET, BY REGION
9. COMPETITIVE LANDSCAPE
10 COMPANY PROFILE
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for North America, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
+1 646 845 9312